928results about "Tin organic compounds" patented technology

Tantalum and titanium source reagents are described, including tantalum amide and tantalum silicon nitride precursors for the deposition of tantalum nitride material on a substrate by processes such as chemical vapor deposition, assisted chemical vapor deposition, ion implantation, molecular beam epitaxy and rapid thermal processing. The precursors may be employed to form diffusion barrier layers on microlectronic device structures enabling the use of copper metallization and ferroelectric thin films in device construction.

A single source precursor for depositing ternary I-III-VI2 chalcopyrite materials useful as semiconductors. The single source precursor has the I-III-VI2 stoichiometry “built into” a single precursor molecular structure which degrades on heating or pyrolysis to yield the desired I-III-VI2 ternary chalcopyrite. The single source precursors effectively degrade to yield the ternary chalcopyrite at low temperature, e.g. below 500° C., and are useful to deposit thin film ternary chalcopyrite layers via a spray CVD technique. The ternary single source precursors according to the invention can be used to provide nanocrystallite structures useful as quantum dots. A method of making the ternary single source precursors is also provided.

The present invention is concerned with compounds of the general Formula I: and pharmaceutically acceptable salts thereof, which are useful as melanin concentrating hormone receptor antagonists, particularly MCH-1R antagonists. As such, compounds of the present invention are useful for the treatment or prevention of obesity or eating disorders associated with excessive food intake and complications thereof, osteoarthritis, certain cancers, AIDS wasting, cachexia, frailty (particularly in elderly), mental disorders stress, cognitive disorders, sexual function, reproductive function, kidney function, locomotor disorders, attention deficit disorder (ADD), substance abuse disorders and dyskinesias, Huntington's disease, epilepsy, memory function, and spinal muscular atrophy. Compounds of formula I may therefore be used in the treatment of these conditions, and in the manufacture of a medicament useful in treating these conditions. Pharmaceutical formulations comprising one of the compounds of formula (I) as an active ingredient are disclosed, as are processes for preparing these compounds.

The invention provides an optoelectronic device comprising a mixed-anion perovskite, wherein the mixed-anion perovskite comprises two or more different anions selected from halide anions and chalcogenide anions. The invention further provides a mixed halide perovskite of the formula (I) [A][B][X]3 wherein: [A] is at least one organic cation; [B] is at least one divalent metal cation; and [X] is said two or more different halide anions. In another aspect, the invention provides the use of a mixed-anion perovskite as a sensitizer in an optoelectronic device, wherein the mixed-anion perovskite comprises two or more different anions selected from halide anions and chalcogenide anions. The invention also provides a photosensitizing material for an optoelectronic device comprising a mixed-anion perovskite wherein the mixed-anion perovskite comprises two or more different anions selected from halide anions and chalcogenide anions.

A class of metallocene compounds is disclosed having the general formula (I):wherein Y is a moiety of formula (II)wherein A, B and D, same or different from each other, are selected from an element of the groups 14 to 16 of the Periodic Table of the Elements (new IUPAC version), with the exclusion of nitrogen and oxygen; R1, R2, R3, R4 and R5 are hydrogen or hydrocarbon groups, Z is selected from a moiety of formula (II) as described above and from a moiety of formula (III):wherein R6, R7, R8 and R9, are hydrogen or hydrocarbon groups; L is a divalent bridging group; M is an atom of a transition metal selected from those belonging to group 3, 4, 5, 6 or to the lanthanide or actinide groups in the Periodic Table of the Elements (new IUPAC version), X, same or different, is hydrogen, a halogen, a R10, OR10, OSO2CF3, OCOR10, SR10, NR102 or PR102 group, wherein the substituents R10 are hydrogen or alkyl groups; p is an integer of from 0 to 3, being equal to the oxidation state of the metal M minus 2.The above metallocenes are particular useful in the polymerization of propylene.

In one embodiment, the invention is a process for the preparation of poly(trimethylene terephthalate) comprising (a) contacting terephthalic acid with 1,3-propanediol in the presence of an organic tin catalyst to form a bis(3-hydroxypropyl)terephthalate monomer; and (b) polymerizing said monomer in the presence of organic titanate polycondensation catalyst to obtain the poly(trimethylene terephthalate). In another embodiment, the invention is a process for the preparation of poly(trimethylene terephthalate) containing less than 1.6 mol % of DPG said process comprising contacting terephthalic acid with a 1.6 to 1 to 2:1 molar amount of 1,3-propanediol in the presence of 20 to 120 ppm (as tin), by weight of the poly(trimethylene terephthalate), of a organic tin catalyst, to form a bis(3-hydroxypropyl)terephthalate monomer and polymerizing said monomer to obtain the poly(trimethylene terephthalate). The invention is also directed to poly(trimethylene terephthalate) produced by the processes.

This invention provides a class of androgen receptor targeting agents (ARTA). The agents define a new subclass of compounds, which are selective androgen receptor modulators (SARM). Several of the SARM compounds have been found to have an unexpected androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. Other SARM compounds have been found to have an unexpected antiandrogenic activity of a nonsteroidal ligand for the androgen receptor. The SARM compounds, either alone or as a composition, are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and / or prevention of acute and / or chronic muscular wasting conditions; e) preventing and / or treating dry eye conditions; f) oral androgen replacement therapy; and / or g) decreasing the incidence of, halting or causing a regression of prostate cancer.

A water slurry process is used to prepare a prepreg and to manufacture articles from macrocyclic polyester oligomers. In one embodiment, a process for preparing a water suspension of macrocyclic polyester oligomers includes the steps of contacting a macrocyclic polyester oligomer and a polymerization catalyst with water and a surfactant, and mixing the macrocyclic polyester oligomer and polymerization catalyst with water and the surfactant thereby forming a suspension. In another embodiment, a process for impregnating macrocyclic polyester oligomers for polymerization includes the steps of providing a suspension of a macrocyclic polyester oligomer and a polymerization catalyst in water, applying the suspension to a base material, drying to remove water from the suspension, and pressing the dried suspension to a desired form. In yet another embodiment, a composition of macrocyclic polyester oligomer includes a macrocyclic polyester oligomer, a polymerization catalyst, and water. In yet another embodiment, a process for polymerizing macrocyclic polyester oligomers includes the steps of mixing a blend material having a macrocyclic polyester oligomer and a polymerization catalyst with water to form a mixture, applying the mixture to a base material, drying to remove water, heating to polymerize the macrocyclic polyester oligomer, and pressing the polymerized macrocyclic polyester oligomer to a desired form.

The lubricating oil composition of the invention comprises a lubricating base oil with a urea adduct value of no greater than 4% by mass and a viscosity index of 100 or higher, an ashless friction modifier at 0.01-10% by mass and a phosphorus-containing anti-wear agent at 0.01-0.2% by mass as phosphorus, based on the total amount of the composition.

A method for preparing multi-functional high-trans elastomeric polymers that have various applications such as in vulcanizable rubber compositions, moisture curable resin compositions, as well as other areas.

This invention provides androgen receptor targeting agents (ARTA). The agents define a new subclass of compounds, which are selective androgen receptor modulators (SARM). Several of the SARM compounds have been found to have an unexpected androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. Other SARM compounds have been found to have an unexpected antiandrogenic activity of a nonsteroidal ligand for the androgen receptor. The SARM compounds, either alone or as a composition, are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and / or prevention of acute and / or chronic muscular wasting conditions; e) preventing and / or treating dry eye conditions; f) oral androgen replacement therapy; and / or g) decreasing the incidence of, halting or causing a regression of prostate cancer

The present invention provides a lubricating base oil comprising saturated components of 90% by mass or greater, wherein the proportion of cyclic saturated components among the saturated components is not greater than 40% by mass, and by having a viscosity index of 110 or higher and an iodine value of not greater than 2.5. The lubricating base oil of the invention exhibits excellent viscosity-temperature characteristics and heat and oxidation stability while also allowing additives to exhibit a higher level of function when additives are included. The lubricating base oil of the invention is suitable for use in various lubricating oil fields, and is especially useful for reducing energy loss and achieving energy savings in devices in which the lubricating base oil is applied.

The invention provides a coordination polymer material with a multistage pore passage structure and a preparation method thereof. The coordination polymer material with a multistage pore passage structure is internally provided with the multistage pore passage structure, the multistage pore passage structure is a microporous and / or mesoporous and / or macroporous multistage pore passage structure which is formed by the self assembly between the metal ion and the organic ligand, the apertures of the micropores are less than or equal to 2nm, the apertures of the mesopores are from 2nm to 50nm, and the apertures of the macropores are more than 50nm. The coordination polymer material with a multistage pore passage structure is large in specific surface, the large-size organic ligand does not need to be synthesized, and the coordination polymer material with larger porous sizes can be obtained without the template agent and the pore assisting agent, so that the invention is simple in preparation method, and low in cost.

A method of using metallized and nonmetallized nanoscopic silicon containing agents for physical property control, radiation absorption, and in situ formation of nanoscopic glass layers on material surfaces. Because of their tailorable compatibility with polymers, metals, composites, ceramics, glasses and biological materials, nanoscopic silicon containing agents can be readily and selectively incorporated into materials at the nanometer level by direct mixing processes. Properties improved include gas and liquid barrier, stain resistance, resistance to environmental degradation, radiation absorption, adhesion, printability, time dependent mechanical and thermal properties such as heat distortion, creep, compression set, shrinkage, modulus, hardness and abrasion resistance, electrical and thermal conductivity, and fire resistance. The materials are useful in a number of applications, including beverage and food packaging, space-survivable materials, microelectronic packaging, and radiation absorptive paints and coatings.

A nonaqueous electrolytic solution having an electrolyte salt dissolved in an organic solvent, which contains a silicon compound having an unsaturated bond which is represented by formula (I): wherein R1, R2, R3, R4, R5, and R6 each represent an alkyl group, an alkoxy group, an alkenyl group, an alkenyloxy group, an alkynyl group, an alkynyloxy group, an aryl group or an aryloxy group, each of which may have an ether bond in the chain thereof; n represents a number of from 0 to 5; when n is 1 to 5, X represents a single bond, an oxygen atom, an alkylene group, an alkylenedioxy group, an alkenylene group, an alkenylenedioxy group, an alkynylene group, an alkynylenedioxy group, an arylene group or an arylenedioxy group; provided that at least one of R1, R2, R3, R4, R5, R6, and X represents a group containing an unsaturated bond,an organotin compound or an organogermanium compound and a nonaqueous secondary battery having the same.

The method of at least one thermally expandable graphite intercalation compound, containingA) a least one metal halide of at least one of the elements Fe, Al, Sb, Zn, Y, Cr and Ni andB) at least one nitroalkane of the general formula CH3(CH2)nNO2, in which n is a whole number from 0 to 10, as well as its structural isomers or mixtures,as intumescing, fire-protection additive in polymer matrices for producing intumescing fire-protective seals for through holes, wall bushings and other openings in walls, floors and / or ceilings of buildings, as well as a method for preparing the thermally expandable graphite-intercalation compounds used.

The invention provides an adduct comprising a carbon nanotube and a transitional metal coordination complex, wherein the metal of the complex is attached by a covalent linkage to at least one oxygen moiety on the nanotube.

A method for the production of a robust, chemically stable, crystalline, passivated nanoparticle and composition containing the same, that emit light with high efficiencies and size-tunable and excitation energy tunable color. The methods include the thermal degradation of a precursor molecule in the presence of a capping agent at high temperature and elevated pressure. A particular composition prepared by the methods is a passivated silicon nanoparticle composition displaying discrete optical transitions.

The present invention relates to high purity monoalkyltin compounds, more specifically to alkyltin compound compositions containing monoalkyltin as major compound, and minor quantities of di- and / or trialkyltin compounds. The present invention also relates to the preparation processes of such high purity monoalkyltin compounds, as well as to the uses of said monoalkyltin compounds as chlorine-containing polymer-stabilisers, glass coating chemicals and catalysts, as well as articles comprising at least one polymer matrix and a high purity monoalkyltin compound.

Methods of preparing Group IVA and Group VIA organometallic compounds, particularly Group IVA organometallic compounds, are provided. Such manufacturing methods employ an amine and / or phosphine catalyst in a transalkylation step and may be performed in a batch, semi-continuous or continuous manner.

This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compounds for inhibiting the aggregation of amyloid proteins to form-amyloid deposits, and a method of delivering a therapeutic agent to amyloid deposits.

The present invention provides a process for preparing benzoprostacycline derivatives of formula (1), i.e. 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives, and vinyl tin compounds of formula (III) as starting materials for the same.

A pigment dispersion comprising pigment, an aqueous carrier selected from water and a mixture of water and at least one organic solvent, and a pigment dispersant is described. The pigment dispersant is prepared by polymerizing (i) at least one prepolymer having a radically polymerizable group, and (ii) at least one second monomer. The prepolymer is prepared by controlled radical polymerization, e.g., atom transfer radical polymerization, of at least one radically polymerizable first monomer. The second monomer forms a polymeric backbone segment of the pigment dispersant, and the prepolymer forms polymeric segments that are pendent to the backbone. The backbone segment of the pigment dispersant is hydrophilic, while at least a portion of each pendent polymeric segment is hydrophobic.

The method of at least one thermally expandable graphite intercalation compound, containing A) a least one metal halide of at least one of the elements Fe, Al, Sb, Zn, Y, Cr and Ni and B) at least one nitroalkane of the general formula CH3(CH2)nNO2, in which n is a whole number from 0 to 10, as well as its structural isomers or mixtures, as intumescing, fire-protection additive in polymer matrices for producing intumescing fire-protective seals for through holes, wall bushings and other openings in walls, floors and / or ceilings of buildings, as well as a method for preparing the thermally expandable graphite-intercalation compounds used.

The lubricating base oil of the invention is characterized by satisfying at least one of the following conditions (a) or (b).(a) A saturated compound content of 95% by mass or greater, and a proportion of 0.1-10% by mass of cyclic saturated compounds among the saturated compounds.(b) The condition represented by the following formula (1).1.435≦n20−0.002×kv100 ≦1.450  (1)wherein n20 represents the refractive index of the lubricating base oil at 20° C., and kv100 represents the kinematic viscosity (mm2 / s) of the lubricating base oil at 100° C.

One aspect of the invention is concerned with cannabimimetic pyrazole analogs. Another aspect of the invention is concerned with new and improved pyrazole analogs having high affinities and / or selectivities for the CB1 cannabinoid receptor. A further aspect of the invention is concerned with pharmaceutical preparations employing the inventive analogs and methods of administering therapeutically effective amounts of the inventive analogs to provide a physiological effect.

An organohalide-flame retardant polymer containing as a stabilizer blend:a) an acid scavenger, for example a hydrotalcite or an amorphous basic aluminum magnesium carbonate;b) a heat stabilizer comprising an organotin compound; andc) a polyhydroxyaliphatic costabilizer.